Literature DB >> 6290921

Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.

J C Buckingham.   

Abstract

The influence of morphine and enkephalins on the functional activity of the hypothalamo-pituitary-adrenocortical system in the rat was studied by investigating their effects on the secretion in vivo and in vitro of corticotrophin (ACTH) by the pituitary gland and corticotrophin-releasing factor (CRF) by the hypothalamus. A single injection of morphine caused a rise followed by a fall in hypothalamic CRF content and increases in the concentrations of ACTH in the plasma and adenohypophysis. In addition, the stress-induced increments in hypothalamic CRF and pituitary and plasma ACTH were exaggerated in morphine-treated rats. The production of ACTH by pituitary segments in vitro was not affected by the addition to the incubation medium of morphine, met-enkephalin, leu-enkephalin or naloxone. However, morphine and the enkephalins stimulated the secretion of CRF by isolated hypothalami and their effects were antagonized by naloxone. The results indicate that morphine and the enkephalins evoke hypothalamo-pituitary-adrenocortical activity by stimulating specific receptors in the hypothalamus and raise the possibility that opioid peptides and their receptors are physiologically important in the control of the secretion of CRF.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290921     DOI: 10.1159/000123364

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  14 in total

Review 1.  Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.

Authors:  S Tsagarakis; A Grossman
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

2.  Neurosteroids in nicotine and morphine dependence.

Authors:  Alessandra Concas; Cristiana Sogliano; Patrizia Porcu; Carla Marra; Andrea Brundu; Giovanni Biggio
Journal:  Psychopharmacology (Berl)       Date:  2005-08-17       Impact factor: 4.530

3.  The stimulating effect of tissue extracts on hypothalamo-pituitary-thyroid axis in rats.

Authors:  P Ren; C R An; J M Lei; J S Sun
Journal:  Acta Acad Med Wuhan       Date:  1984

Review 4.  Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.

Authors:  Marian L Logrip; George F Koob; Eric P Zorrilla
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

5.  Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus.

Authors:  S Ceccatelli; A Cintra; T Hökfelt; K Fuxe; A C Wikström; J A Gustafsson
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 6.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

7.  Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats.

Authors:  E C degli Uberti; F Petraglia; M Bondanelli; A L Guo; A Valentini; S Salvadori; M Criscuolo; R E Nappi; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

8.  Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.

Authors:  Yan Zhou; Francesco Leri; Ann Ho; Mary Jeanne Kreek
Journal:  Neurochem Res       Date:  2013-06-16       Impact factor: 3.996

9.  Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation.

Authors:  A Stiene-Martin; J A Gurwell; K F Hauser
Journal:  Brain Res Dev Brain Res       Date:  1991-05-20

Review 10.  Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.

Authors:  Marisa Roberto; Samantha R Spierling; Dean Kirson; Eric P Zorrilla
Journal:  Int Rev Neurobiol       Date:  2017-08-07       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.